D
Lantern Pharma Inc. LTRN
$3.75 -$0.18-4.58%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -25.96% -24.46% -25.19% -11.93% -5.12%
Total Depreciation and Amortization 100.20% 71.95% 44.62% 17.87% 55.01%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -117.40% -81.14% -57.70% -53.88% -39.24%
Change in Net Operating Assets 4,488.49% 223.90% 360.68% 187.92% 362.42%
Cash from Operations -26.39% -8.54% -3.49% -12.37% -12.30%
Capital Expenditure 29.47% 27.43% 67.12% 32.62% 0.96%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 134.27% 70.71% 44.29% -540.29% 11.60%
Cash from Investing 130.54% 69.60% 45.15% -618.80% 11.27%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- -100.00%
Repurchase of Common Stock -- -- -- 79.86% 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- -- 77.09% 100.00%
Foreign Exchange rate Adjustments 194.16% -354.10% -85.47% -167.92% 29.38%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -22.78% -7.02% -3.45% -6.93% 10.35%
Weiss Ratings